Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Patients receiving an antipsychotic should be treated with structured lifestyle modifications to promote weight loss and weight gain prevention
In the SURPASS program for type 2 diabetes, tirzepatide demonstrated A1C reductions of 2.07-2.59% across doses, with up to 97% of participants achieving A1C below 7.0%
The combination of significant weight reduction and effective glycemic control across diverse patient populations makes GLP-1 receptor agonists highly attractive, fueling their adoption worldwide and establishing them as a cornerstone in obesity and diabetes management
Improved Insulin Sensitivity : GLP-1 promotes insulin secretion in response to meals, helping improve blood sugar levels and reduce fat storage, which is crucial for effective weight management
US$ 25.24
US$ 25.04
US$ 29.44
US$ 25.86
US$ 20.82
US$ 25.99
US$ 23.87
US$ 27.29
US$ 23.87
US$ 22.93
